Screening for anal cancer in women with HIV
Part of Cancer, Infections clinical trials.
This study is looking at better ways to screen for anal cancer and its early warning signs in women living with HIV. Early detection could help prevent cancer from developing, so joining may help you get closer check-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with HIV
- You are 45 years old or older
- You get your HIV care at one of the three participating hospitals in Stockholm or Gothenburg
- You have never been diagnosed with anal cancer
- You have not had surgery to remove your rectum
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early anal cell changes in women who have had high-grade HPV-related problems in the cervix, vagina, or vulva. It may help find concerning changes sooner, using a structured screening exam.
This study looks at using a simple swab to screen for HPV (the virus that can cause anal cancer) in people living with HIV. By collecting a sample from the anal area, the study aims to find a less invasive way to check for risk, helping you avoid more uncomfortable procedures unless needed.
This trial compares two ways to screen for HPV, a virus linked to anal cancer. People living with HIV will either collect their own sample or have a doctor do it, then switch methods. The goal is to see which is more comfortable and accurate.
This study compares self-sampling (doing your own swab) to a healthcare professional doing the swab for HPV, a virus that can lead to anal cancer. It is for people with HIV on Réunion Island.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
This trial checks whether anal cancer screening is useful for women age 40 and older who previously had high-grade vulvar pre-cancer (VIN 2/3) or vulvar cancer. It may help find serious problems earlier in people at higher risk.
Hear when a new Anal Canal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.